Skip to content

CP-A2

C47H52F2N14O6 — CID 155525769

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC2-(2,6-dioxopiperidin-3-yl)-4-[2-[2-[2-[4-[[4-[[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl]piperazin-1-yl]methyl]triazol-1-yl]ethoxy]ethoxy]ethylamino]isoindole-1,3-dione
SMILESCc1nc2c(F)cc(-c3nc(Nc4ccc(CN5CCN(Cc6cn(CCOCCOCCNc7cccc8c7C(=O)N(C7CCC(=O)NC7=O)C8=O)nn6)CC5)cn4)ncc3F)cc2n1C(C)C
InChIInChI=1S/C47H52F2N14O6/c1-28(2)62-29(3)53-43-34(48)21-31(22-38(43)62)42-35(49)24-52-47(56-42)54-39-9-7-30(23-51-39)25-59-12-14-60(15-13-59)26-32-27-61(58-57-32)16-18-69-20-19-68-17-11-50-36-6-4-5-33-41(36)46(67)63(45(33)66)37-8-10-40(64)55-44(37)65/h4-7,9,21-24,27-28,37,50H,8,10-20,25-26H2,1-3H3,(H,55,64,65)(H,51,52,54,56)
InChIKeyMMXACPGYKXVBCK-UHFFFAOYSA-N
MW947.02 g/mol
LogP4.26
Rot. Bonds19

About CP-A2

CP-A2 (PubChem CID 155525769) has the molecular formula C47H52F2N14O6 and a molecular weight of 947.02 g/mol. Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)-4-[2-[2-[2-[4-[[4-[[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl]piperazin-1-yl]methyl]triazol-1-yl]ethoxy]ethoxy]ethylamino]isoindole-1,3-dione.

Molecular Properties

Compound NameCP-A2
PubChem CID155525769
Molecular FormulaC47H52F2N14O6
Molecular Weight947.02 g/mol
Exact Mass946.42
IUPAC Name2-(2,6-dioxopiperidin-3-yl)-4-[2-[2-[2-[4-[[4-[[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl]piperazin-1-yl]methyl]triazol-1-yl]ethoxy]ethoxy]ethylamino]isoindole-1,3-dione
SMILESCc1nc2c(F)cc(-c3nc(Nc4ccc(CN5CCN(Cc6cn(CCOCCOCCNc7cccc8c7C(=O)N(C7CCC(=O)NC7=O)C8=O)nn6)CC5)cn4)ncc3F)cc2n1C(C)C
InChIInChI=1S/C47H52F2N14O6/c1-28(2)62-29(3)53-43-34(48)21-31(22-38(43)62)42-35(49)24-52-47(56-42)54-39-9-7-30(23-51-39)25-59-12-14-60(15-13-59)26-32-27-61(58-57-32)16-18-69-20-19-68-17-11-50-36-6-4-5-33-41(36)46(67)63(45(33)66)37-8-10-40(64)55-44(37)65/h4-7,9,21-24,27-28,37,50H,8,10-20,25-26H2,1-3H3,(H,55,64,65)(H,51,52,54,56)
InChIKeyMMXACPGYKXVBCK-UHFFFAOYSA-N
XLogP4.26
TPSA219.75 Ų
H-Bond Donors3
H-Bond Acceptors18
Rotatable Bonds19
Heavy Atoms69
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500947.02
LogP ≤ 54.26
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze CP-A2 with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of CP-A2?
The IUPAC name of CP-A2 (CID 155525769) is 2-(2,6-dioxopiperidin-3-yl)-4-[2-[2-[2-[4-[[4-[[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl]piperazin-1-yl]methyl]triazol-1-yl]ethoxy]ethoxy]ethylamino]isoindole-1,3-dione.
What is the SMILES notation for CP-A2?
The canonical SMILES for CP-A2 is Cc1nc2c(F)cc(-c3nc(Nc4ccc(CN5CCN(Cc6cn(CCOCCOCCNc7cccc8c7C(=O)N(C7CCC(=O)NC7=O)C8=O)nn6)CC5)cn4)ncc3F)cc2n1C(C)C.
What is the InChIKey of CP-A2?
The InChIKey is MMXACPGYKXVBCK-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H52F2N14O6/c1-28(2)62-29(3)53-43-34(48)21-31(22-38(43)62)42-35(49)24-52-47(56-42)54-39-9-7-30(23-51-39)25-59-12-14-60(15-13-59)26-32-27-61(58-57-32)16-18-69-20-19-68-17-11-50-36-6-4-5-33-41(36)46(67)63(45(33)66)37-8-10-40(64)55-44(37)65/h4-7,9,21-24,27-28,37,50H,8,10-20,25-26H2,1-3H3,(H,55,64,65)(H,51,52,54,56).
What are the key properties of CP-A2?
CP-A2 has a molecular weight of 947.02 g/mol, XLogP of 4.26, 19 rotatable bonds, 3 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for CP-A2 is sourced from PubChem (CID 155525769), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.